 
The Patent Office Journal 31/08/2012 
13759
(12) PATENT APPLICATION PUBLICATION (21) Application No.754/MUMNP/2012 A 
(19) INDIA  
(22) Date of filing of Application :26/03/2012 (43) Publication Date : 31/08/2012 
  
(54) Title of the invention : DRUG FUSIONS AND CONJUGATES WITH EXTENDED HALF LIFE  
  
(51) International classification  :A61P 3/08  
(31) Priority Document No  :61/247,346  
(32) Priority Date  :30/09/2009 
(33) Name of priority country  :U.S.A. 
(86) International Application No 
        Filing Date 
:PCT/EP10/064020
:23/09/2010 
(87) International Publication No  :WO/2011/039096 
(61) Patent of Addition to Application Number 
        Filing Date 
:NA 
:NA 
(62) Divisional to Application Number 
        Filing Date 
:NA 
:NA  
  
(71)Name of Applicant :  
   1)GLAXO GROUP LIMITED 
      Address of Applicant :GLAXO WELLCOME HOUSE, 
BERKELEY AVENUE, GREENFORD MIDDLESEX UB6 0NN 
UNITED KINGDOM. 
(72)Name of Inventor : 
   1)HAMILTON, BRUCE 
   2)HERRING, CHRISTOPHER 
   3)PAULIK, MARK, ANDREW  
(57) Abstract : 
The present invention relates to drag fusions and conjugates that have improved serum half lives. These fusions and conjugates 
comprise immunoglobulin (antibody) single variable domains and insulinotropic and/or incretin and/or gut peptide molecules. The 
invention further relates to uses, formulations, compositions and devices comprising such drug fusions and conjugates. The invention 
also relates to compositions which comprise more than one insulinotropic and/or incretin and/or gut peptide molecules present as part 
of a fusion or conjugate and to uses and formulations thereof. 
  
  
No. of Pages : 100 No. of Claims : 46 
